(Q42849666)

English

Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients

scientific article published on October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

author name string

V López

1

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

M Martin

2

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

C Cobelo

3

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

P Aranda

4

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

M Cabello

5

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

E Sola

6

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

C Gutierrez

7

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

D Burgos

8

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

D Martínez

9

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

D Hernandez

10

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

language of work or name

0 references

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

2883-2885

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.053

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.053

7 January 2021

The renin angiotensin system blockade in kidney transplantation: pros and cons

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.053

7 January 2021

Aliskiren--mode of action and preclinical data

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.053

7 January 2021

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.053

7 January 2021

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.053

7 January 2021

Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.07.053

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2010.07.053

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42849666&oldid=2104455889"